Pentixapharm Holding AG (FRA:PTP)

Germany flag Germany · Delayed Price · Currency is EUR
2.520
-0.045 (-1.75%)
Last updated: Jun 2, 2025
-50.59%
Market Cap 59.73M
Revenue (ttm) 137.00K
Net Income (ttm) -16.86M
Shares Out n/a
EPS (ttm) -0.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 41,071
Average Volume 21,329
Open 2.645
Previous Close 2.565
Day's Range 2.500 - 2.645
52-Week Range 2.375 - 5.150
Beta n/a
RSI 31.23
Earnings Date Aug 7, 2025

About Pentixapharm Holding AG

Pentixapharm Holding AG, a clinical-stage biopharmaceutical company, develops radiopharmaceuticals. The company focuses on developing CXCR4 ligand-based technology, which includes PentixaFor (PT-001), a tracer based on Gallium-68, used to diagnose and monitor the progress of various diseases, including hematological and solid tumors, as well as endocrine, cardiovascular, and immunological disorders; and PentixaTher (PT-002), a therapeutic radiopharmaceutical based on Yttrium-90 and Lutetium-177, for the treatment of leukemia, which is in Phase ... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2019
Employees 75
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol PTP
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.